Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

about

From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action.Convergent QSAR studies on a series of NK₃ receptor antagonists for schizophrenia treatment.Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines.

P2860

Q42620551-2FC45A8D-AE95-4701-AACE-7893F4BCC9E5 Q47723793-319E68A9-1533-4AA5-B5A8-D78C91F2EC81 Q47951453-188F178F-69C6-4F9C-8D77-C856D72C9A87

P2860

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

Item

http://www.wikidata.org/entity/Q39787316

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

@en

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.

@nl

type

Item

label

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

@en

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.

@nl

prefLabel

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

@en

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.

@nl

P1476

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

@en

P2093

Clotilde Mannoury la Cour

http://www.w3.org/2001/XMLSchema#string

Guillaume De Nanteuil

http://www.w3.org/2001/XMLSchema#string

Mark J Millan

http://www.w3.org/2001/XMLSchema#string

Nicolas Boyer

http://www.w3.org/2001/XMLSchema#string

Stephen Hanessian

http://www.w3.org/2001/XMLSchema#string

Thomas Jennequin

http://www.w3.org/2001/XMLSchema#string

Udaykumar Soma

http://www.w3.org/2001/XMLSchema#string

Vincent Babonneau

http://www.w3.org/2001/XMLSchema#string

P2860

Tachykinins and tachykinin receptors: structure and activity relationships

Opinion: NK3 receptor antagonists: the next generation of antipsychotics?

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

Multi-target drugs: the trend of drug research and development

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes.

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes.

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

Asymmetric Suzuki cross-couplings of activated secondary alkyl electrophiles: arylations of racemic alpha-chloroamides

Asymmetric alkyl-alkyl cross-couplings of unactivated secondary alkyl electrophiles: stereoconvergent Suzuki reactions of racemic acylated halohydrins

Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

P304

550-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML400528Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24900878

http://www.w3.org/2001/XMLSchema#string

P932

4027792

http://www.w3.org/2001/XMLSchema#string

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

about

P2860

P2860

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932